Skip to main content

Table 1 Patients’ demographics and tumor characteristics (N = 39)

From: Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center

Characteristic

No

%

Age (years)

 ˂ 50 years

29

74.4

 ≥ 50 years

10

25.6

 Mean

45.9

 Standard deviation (SD)

6.9

ECOG PS

 0, I

11

18.3

 II

28

81.7

Menopausal status

 Pre/perimenopausal

26

66.6

 postmenopausal

13

33.3

Pathological type

 IDC

34

87.2

 ILC

4

10.3

 Others

1

2.6

Tumor grade

 Grade I or II

33

84.6

 Grade III

6

15.4

Type of metastasis

 De novo MBC

8

20.5

 Recurrent MBC

31

79.5

No of metastasized organ/s

 One

5

12.8

 Two or more

34

87.2

Order of PLD line

 3rd palliative

13

33.3

 4th palliative or more

26

66.6

Chemosensitivity

 Chemosensitive

14

35.9

 Chemoresistant

25

64.1

Chemotherapy cycles

 Total number

222

 Mode

3

 Range

3–18

  1. Abbreviations: ECOG Eastern Cooperative Oncology Group, IDC invasive ductal carcinoma, ILC infiltrating lobular carcinoma, Her 2 human epidermal growth factor receptor 2, PS performance status, SD standard deviation